Rejuve.AI
RJV
Evaluation Score
Overall rating on a scale of 0-10
Dimension Breakdown
AI Analysis
Comprehensive evaluation of the token
Rejuve.AI (RJV) is a decentralized longevity research network incubated by SingularityNET that rewards users with tokens for contributing health data. While the project features a public leadership team led by CEO Jasmine Smith and continuous baseline development on its Longevity App and AI models, it faces severe fundamental risks. The token suffers from extreme micro-cap illiquidity with 24-hour trading volumes often falling under $500, a market capitalization around $172K–$200K, and an unrecovered price collapse of over 94% to 99% from its all-time high. Furthermore, RJV is deployed across multiple chains (Ethereum, Cardano, and BSC) without any verified third-party smart contract audits in the retrieved records, exposing it to heightened bridge and wrapping vulnerabilities. Governance remains nascent with minimal documented community participation. With no qualifying red-flag events affirmatively established, the overall score mathematically reflects the weighted section average of 4.6.
Development Activity
Code updates and developer engagement
Community Support
Social media presence and community engagement
Tokenomics
Supply, distribution, and utility
Market & Use Case
Value proposition and competitive landscape
Team & Governance
Team background and project governance
Security & Audits
Security history and audit status
About Rejuve.AI (RJV)
Rejuve.AI (RJV) is an artificial intelligence-driven longevity research network within the decentralized science (DeSci) sector, originally incubated as a spin-off from SingularityNET. The platform is designed to aggregate health and biometric data contributed by users through its Longevity App, surveys, and wearable device integrations. This data is utilized alongside analytical tools, such as BayesNet AI models, to support research into aging and health span extension. The project is led by a public team headed by Chief Executive Officer Jasmine Smith.
The RJV token functions as the core utility and governance asset of the network, operating across multiple blockchains including Ethereum, Cardano, and Binance Smart Chain. It has a fixed maximum supply of 1 billion tokens, with its initial distribution split between Ethereum (64.79%) and Cardano (35.21%) via a 1:1 convertibility mechanism. Users earn RJV as compensation for contributing personal health data, and the token can be utilized for staking, accessing platform-related health products and services, and participating in quadratic voting on governance proposals.
The project faces significant market, operational, and security-related challenges. RJV has experienced an extensive market drawdown, falling between 94% and 99% from its all-time high, and operates as a micro-cap asset with a market capitalization between $172,000 and $200,000 and functionally illiquid 24-hour trading volumes that frequently fall below $500. Additionally, the project lacks verified, published third-party smart contract audit reports across its multi-chain contracts and bridges, while its governance structures remain nascent with low recorded voter turnout and centralized management.